SARS-CoV-2 nucleic acid – Communicable Diseases Research

Evaluation of indirect sequence-specific magneto-extraction-aided LAMP for fluorescence and electrochemical SARS-CoV-2 nucleic acid detection

Article

Published on 2023-01-152022-11-15
Journal: Talanta
[Category] SARS, 변종, 치료기술, 치료제,

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study

Article

Published on 2022-10-262022-11-15
Journal: mBio
[Category] COVID19(2023년), SARS, 진단,

[키워드] 95% CI 95% confidence interval acute respiratory syndrome addition adopted Adverse adverse event AEs amplification antibodies CCP Clinical outcome competing Concentration conducted convalescent convalescent plasma coronavirus COVID-19 death defined donors dose response Effectiveness eligible evaluate evaluated event Fisher Gray hazard ratio heterogeneity high-risk population hospital hospital discharge immunology Inconclusive Infection Lower Mortality NAb Neutralizing antibodies neutralizing antibodies. neutralizing antibody observational study occurred participant Patient positive primary clinical outcome randomized control trial receiving Registered Research Respiratory Support Result risk SAEs SARS-CoV-2 SARS-CoV-2 nucleic acid screened Secondary outcomes severe COVID-19 Standard of care Support Symptom therapeutic therapy time titer Treatment
[DOI] 10.1128/mbio.01751-22 PMC 바로가기

[Clinical features of children and their family members with family clusters of SARS-CoV-2 Omicron variant infection in Shanghai, China: an analysis of 380 cases]

Article

Published on 2022-10-152022-11-16
Journal: Zhongguo dang dai er ke za zhi = Chinese journal o
[Category] COVID19(2023년), SARS, 변종,

[키워드] abdominal pain acute respiratory syndrome Admission Adults Analysis Child children Chinese clinical clinical feature clinical manifestation Cluster coronavirus coronavirus disease Coronavirus disease 2019 cough COVID-19 diarrhea disease drugs English family Family cluster infection feature Fever group hospital in both group in both groups incidence rate Infection interferon itching Mild mild case nasal omicron omicron variant. Pain Patient positive Prognosis proportion respiratory Retrospective analysis SARS-CoV-2 SARS-CoV-2 nucleic acid SARS-CoV-2 vaccine Shanghai Symptom Tablet their family member underlying disease vaccination rate variant was performed wheezing
[DOI] 10.7499/j.issn.1008-8830.2205179 PMC 바로가기

COVID-19 in New South Wales children during 2021: severity and clinical spectrum

Article

Published on 2022-09-192022-11-16
Journal: The Medical journal of Australia
[Category] COVID19(2023년), SARS, 변종,

[키워드] 95% CI acute respiratory syndrome adjusted odds ratio Admission Admissions age analyses Analysis Asymptomatic Care Childhood diseases children chronic respiratory disease clinical factor cohort study coronavirus coronavirus disease COVID-19 declined delta variant Epidemics Frequency greater Health home care Home care services, hospital-based hospital Hospital admission hospitalised infancy Infants infections Inflammatory intensive care likelihood Local Medical conditions Morbidity. MOST network New outbreak outcome positive Prospective random SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleic acid severity South syndrome Virtual care were recorded wheeze with mild disease
[DOI] 10.5694/mja2.51661 PMC 바로가기

Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2-18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study

Clinical Trial

Published on 2022-09-012022-10-05
Journal: The Lancet. Infectious Diseases
[Category] COVID19(2023년), SARS, 임상, 진단,

[키워드] 95% CI Administered Adults adverse event age all age group antibody baseline Bharat Biodefense children clinical conducted COVID-19 vaccine curtail deaths decrease demonstrated dose Efficacy eight eligible Endpoint enrolled female Fever for inclusion geometric mean GMT ratio GMTs group groups healthy children hospital Hyderabad immunogenicity immunosuppressive inactivated Inactivated vaccine India Infection injection site pain intramuscular dose less Local local reaction male Mild Mild-to-moderate multicentre neutralisation test neutralising antibody response neutralising antibody titre no difference Open-label Pain pandemic participant Phase 2 study phase 2/3 platform positive PRNT Reactions reactogenicity reduction Registered registry reported safety profile SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleic acid SARS-CoV-2 vaccine second dose Serious Adverse Events seroconverted serology test serum sample severity of COVID-19 susceptible Symptom three group titre Trial were excluded Withdrawal
[DOI] 10.1016/S1473-3099(22)00307-3 PMC 바로가기 [Article Type] Clinical Trial

SLIDE: Saliva-Based SARS-CoV-2 Self-Testing with RT-LAMP in a Mobile Device

슬라이드: 모바일 장치에서 RT-LAMP를 사용한 타액 기반 SARS-CoV-2 자가 테스트

Article

Published on 2022-08-262022-09-11
Journal: ACS Sensors
[Category] SARS, 치료기술, 치료제,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 amplification Antigen antigen tests automatically benefit Chain Reaction clinical samples communication comparable complexity coronavirus COVID-19 Device functions infected patients isothermal amplification lab LAMP less limit of detection Loop-mediated isothermal amplification miss a Mobile noninvasive nucleic acid nucleic acid testing pandemic Pandemics platform POCT polymerase chain polymerase chain reaction qRT-PCR Quantitative rapid antigen test Rapid antigen tests Regular reverse transcription RT-LAMP RT-PCR Saliva SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 nucleic acid Self-testing. sensitivity Sensitivity and specificity sequence severe acute respiratory syndrome Coronavirus the SARS-CoV-2 virus particle
[DOI] 10.1021/acssensors.2c01023 PMC 바로가기 [Article Type] Article

Can we get out of the COVID pandemic without adequate vaccination coverage in the pediatric population?

소아 인구에 적절한 예방 접종 범위가 없으면 COVID 전염병에서 벗어날 수 있습니까?

Article

Published on 2022-08-192022-09-11
Journal: Italian Journal of Pediatrics
[Category] SARS, 변종, 치료기술,

[키워드] age all subjects approved booster Can children contrary Coverage COVID COVID-19 COVID-19 incidence COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines death delta variant diagnosed diffusion dose epidemiological epidemiological surveillance Epidemiology evidenced explain General population greater groups Hospitalization Infant Infection Infectious diseases Italy lower risk manuscript minor nucleic acid Older pandemic pediatric Pediatric case pediatric cases pediatric cohort Pediatric infectious diseases Population positive prolongation proportion rapid increase real-time reverse-transcriptase polymerase-chain-reaction recorded recruited remained RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleic acid SARS-CoV-2. severe disease significant increase specimen subject Surveillance susceptible vaccination vaccine dose virus
[DOI] 10.1186/s13052-022-01339-x PMC 바로가기 [Article Type] Article

Performance and application evaluation of SARS-CoV-2 antigen assay

SARS-CoV-2 항원 분석의 성능 및 응용 평가

Review

Published on 2022-08-012022-09-11
Journal: Journal of medical virology
[Category] COVID19(2023년), SARS, 변종, 치료기술,

[키워드] Accessibility accumulated acute respiratory syndrome acute respiratory syndrome coronavirus addition alleviate Antigen antigen detection approved Asymptomatic can not Clinical data coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 diagnosis COVID-19 vaccines diagnoses Diagnosis False positive False positives gold gold standard hospitals increase in Interpretation Laboratory laboratory diagnosis mutant mutant strain Mutant strains Negative predictive value nucleic acid Nucleic acid detection offer performance positive result Practitioner Predictive value Prevalence Probability promote reagent SARS-CoV-2 SARS-CoV-2 antigen SARS-COV-2 infection SARS-CoV-2 nucleic acid sensitivity Sensitivity and specificity severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 specificity specificity. speed the SARS-CoV-2 the WHO trade-off WHO
[DOI] 10.1002/jmv.27798 PMC 바로가기 [Article Type] Review

Comparison of Severe Maternal Morbidities Associated With Delivery During Periods of Circulation of Specific SARS-CoV-2 Variants

특정 SARS-CoV-2 변이체의 순환 기간 동안 분만과 관련된 심각한 산모 이환율의 비교

Multicenter Study

Published on 2022-08-012022-09-11
Journal: JAMA Network Open
[Category] SARS, 변종,

[키워드] age Alpha Alpha variant amplification analyzed association B.1.1.7 B.1.617.2 cause center characterized clinical variable cohort study complications Control COVID-19 defined delivery Delta delta variant demographic and clinical variables disease control dominant evaluate event events Evidence evidence of example health system highest Hospitalization individual Infection IQR Maternal median morbidity multicenter nucleic acid nucleic acid amplification test Odds ratio omicron outcome outcomes over pandemic Patient patients with SARS-CoV-2 Period predominant pregnant patient pregnant patients prevention preventive measures Primary outcome reflected Respiratory complications retrospective cohort study risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleic acid secondary Secondary outcomes severity of COVID-19 significantly higher Specific Strains test result the SARS-CoV-2 type strain Variation viral strain viral strains was increased while wild-type strain
[DOI] 10.1001/jamanetworkopen.2022.26436 PMC 바로가기 [Article Type] Multicenter Study

[Change in serum IgG antibody during the recovery stage of Omicron variant infection in children: an analysis of 110 cases]

[소아 오미크론 변이체 감염 회복기 혈청 IgG 항체 변화 : 110건 분석]

Article

Published on 2022-07-152022-09-11
Journal: Zhongguo dang dai er ke za zhi = Chinese journal o
[Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age Analysis antibody BBIBP-CorV Beijing Biological Biological products booster vaccination caused Child children China Chinese citation Clinical data Complete coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 diagnosed Diagnosis disease dose doses English four group four groups groups IgG IgG antibody inactivated Inactivated vaccine Infection journal no significant difference no significant differences Nucleic acid detection omicron pediatrics protective effect RBD IgG Recovery stage reduction in respiratory Retrospective analysis route SARS-CoV-2 SARS-CoV-2 IgG antibody SARS-CoV-2 nucleic acid SARS-CoV-2 vaccination SARS-CoV-2 vaccine serum IgG Serum level severe acute respiratory syndrome Coronavirus Sex significant difference significant differences significantly higher significantly lower Sinopharm status the vaccine Tianjin Transmission two group two groups vaccination vaccination. Vaccine variant was performed
[DOI] 10.7499/j.issn.1008-8830.2204074 PMC 바로가기 [Article Type] Article